Insulin-loaded calcium pectinate nanoparticles: Effects of pectin molecular weight and formulation pH

被引:42
作者
Cheng, K [1 ]
Lim, LY [1 ]
机构
[1] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore
关键词
pectin nanoparticles; insulin; pH; molecular weight; association efficiency; cross-flow filtration;
D O I
10.1081/DDC-120030930
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Insulin-loaded calcium pectinate nanoparticles were prepared as a potential colonic delivery system by ionotropic gelation with calcium ions. The effects of pectin molecular weight (M-v) and formulation pH on the characteristics of the nanoparticles were evaluated. Commercial pectins, LM101 and LM104, with respective degrees of esterification of 36% and 28%, were depolymerized by mechanical milling to give Mv ranging from 89 to 5.6 kDa. Milled pectins did not yield nanoparticles with significantly different mean diameter and insulin association efficiency (AE) compared to nanoparticles of umnilled pectins. LM104 nanoparticles had smaller variation in mean size than the LM101 nanoparticles. Formulation pH significantly influenced the AE and stability of the nanoparticles. Increasing the pH from 2 to 3 enhanced the AE by three-fold, from 32.76% to 93.31%, at an insulin loading concentration of 80 U/mL. This increase in AE was correlated to the charge density on the pectin molecules as a function of pH. Subsequent release of associated insulin from the nanoparticles was dependent on the extent of dilution of the nanoparticle dispersion and the pH of the dissolution medium. Cross-flow filtration could be used to separate the nanoparticles from unassociated ions and molecules, without compromising the characteristics of the nanoparticles.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 25 条
[1]   The use of scintigraphy to provide ''proof of concept'' for novel polysaccharide preparations designed for colonic drug delivery [J].
Adkin, DA ;
Kenyon, CJ ;
Lerner, EI ;
Landau, I ;
Strauss, E ;
Caron, D ;
Penhasi, A ;
Rubinstein, A ;
Wilding, IR .
PHARMACEUTICAL RESEARCH, 1997, 14 (01) :103-107
[2]  
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
[3]  
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P13
[4]   Oral insulin delivery [J].
Carino, GP ;
Mathiowitz, E .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 35 (2-3) :249-257
[5]   THERMODYNAMICS OF THE PROTON DISSOCIATION OF NATURAL POLYURONIC ACIDS [J].
CESARO, A ;
DELBEN, F ;
PAOLETTI, S .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1990, 12 (03) :170-176
[6]  
*COP PECT AS, 1998, GENU PECT GEN DESCR
[7]   Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin [J].
Damge, C ;
Vranckx, H ;
Balschmidt, P ;
Couvreur, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (12) :1403-1409
[8]   OVERCOMING BARRIERS TO THE ORAL-ADMINISTRATION OF PEPTIDE DRUGS [J].
DAVIS, SS .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (09) :353-355
[9]   CALIBRATION AND APPLICATION OF HIGH-PERFORMANCE SIZE EXCLUSION COLUMNS FOR MOLECULAR-WEIGHT DISTRIBUTION OF PECTINS [J].
DECKERS, HA ;
OLIEMAN, C ;
ROMBOUTS, FM ;
PILNIK, W .
CARBOHYDRATE POLYMERS, 1986, 6 (05) :361-378
[10]   Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery [J].
Ei-Gibaly, I .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 232 (1-2) :199-211